University of Texas Southwestern Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).
University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.
University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.
Top-decile sponsor footprint
University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
837 total, page 2 of 17
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1
NCT06353321
The Effect of Adiposity on Muscle and Microvascular Function in HFpEF
NCT06930495
Invert-Prospective Phase II Randomized Trial of Involved Nodal Versus Elective Neck RadioTherapy
NCT06477692
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
NCT06659952
Transcutaneous Auricular Neurostimulation After Lumbar Surgery
NCT06100172
Optical Coherence Tomography Angiography in Neurological Disease
NCT06797765
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
NCT06444269
Effect of the Stellate Ganglion Block on the Retinal Microcirculation
NCT06797752
Aging, Beta Blockers, and Thermoregulatory Responses
NCT06582680
Ketamine for Methamphetamine Use Disorder
NCT06496750
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
NCT06394570
EGCG for Hepatocellular Carcinoma Chemoprevention
NCT06015022
Sickle Cell Kidney Biorepository
NCT07064174
Monitoring System for Cranial Orthoses
NCT06425172
Transference of Established Simulated Skills (TEST) Trial
NCT06572033
Skin Wetting in Burn Survivors
NCT06529757
Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
NCT06398158
Hyperpolarized 13C Pyruvate-MRI and FDG-PET in a Single Exam for the Prognosis of Ischemic Cardiomyopathy
NCT06814587
Accelerated rTMS for Substance Use Disorder and Depression
NCT06424184
Comprehensive Optimization At-time of Radical Cystectomy Intervention
NCT05714826
Cerebellar tDCS Stimulation in Children and Adult Women With Anorexia Nervosa Disorder
NCT06286930
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
NCT06130059
Action Regulation Behavioral
NCT06489483
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
NCT05998863
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
NCT05576974
Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
NCT06080503
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
NCT06266338
Polypill for Prevention of Cardiomyopathy
NCT06143566
PSMA PET Response Guided SabR in High Risk Pca
NCT06044857
Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
NCT06292104
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
NCT06218355
Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
NCT05886816
Targeting Social Function in Anxiety and Eating Disorders
NCT06198023
Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
NCT05849077
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
NCT05145816
Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
NCT05816343
Artificial Intelligence Prediction Tool in Non-muscle Invasive Bladder Cancer (NMIBC)
NCT05825950
National Liver Cancer Screening Trial
NCT06084234
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
NCT05931393
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
NCT06003348
Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression
NCT05966532
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
NCT06184152
Diuretic Tuner Clinical Decision Support
NCT04759274
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
NCT05982730
Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury
NCT06480838
PET/MR for Characterization of Renal Masses (RMs)
NCT06076538
Cool Prime Comparative Effectiveness Study for Mild HIE
NCT04621279
Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
NCT05723679
Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability
NCT06047028
Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project
NCT05691283
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 106 |
| Phase 2 | 122 |
| Phase 3 | 28 |
| Phase 4 | 98 |
Therapeutic Areas
What is open in the University of Texas Southwestern Medical Center pipeline
162 recruiting of 837 indexed (19% open); 503 completed (60%).
Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Hypertension (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas Southwestern Medical Center: open-pipeline peers nationwide
Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 837 trials (± recruiting share)
- University of Utah · 818 trials · 17% recruiting
- University of Chicago · 796 trials · 20% recruiting
- Indiana University · 890 trials · 18% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- California Polytechnic State University-San Luis Obispo · 19% recruiting · 26 trials
- Phoenix Children's Hospital · 19% recruiting · 26 trials
- Ann & Robert H Lurie Children's Hospital of Chicago · 19% recruiting · 159 trials
- Vanderbilt University Medical Center · 19% recruiting · 677 trials
Related
What to do with this University of Texas Southwestern Medical Center page
837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.
- 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.